These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 10449429)

  • 1. Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice.
    Barton-Davis ER; Cordier L; Shoturma DI; Leland SE; Sweeney HL
    J Clin Invest; 1999 Aug; 104(4):375-81. PubMed ID: 10449429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gentamicin fails to increase dystrophin expression in dystrophin-deficient muscle.
    Dunant P; Walter MC; Karpati G; Lochmüller H
    Muscle Nerve; 2003 May; 27(5):624-7. PubMed ID: 12707984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negamycin restores dystrophin expression in skeletal and cardiac muscles of mdx mice.
    Arakawa M; Shiozuka M; Nakayama Y; Hara T; Hamada M; Kondo S; Ikeda D; Takahashi Y; Sawa R; Nonomura Y; Sheykholeslami K; Kondo K; Kaga K; Kitamura T; Suzuki-Miyagoe Y; Takeda S; Matsuda R
    J Biochem; 2003 Nov; 134(5):751-8. PubMed ID: 14688241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel approach to identify Duchenne muscular dystrophy patients for aminoglycoside antibiotics therapy.
    Kimura S; Ito K; Miyagi T; Hiranuma T; Yoshioka K; Ozasa S; Matsukura M; Ikezawa M; Matsuo M; Takeshima Y; Miike T
    Brain Dev; 2005 Sep; 27(6):400-5. PubMed ID: 16122626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
    Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
    Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence specificity of aminoglycoside-induced stop condon readthrough: potential implications for treatment of Duchenne muscular dystrophy.
    Howard MT; Shirts BH; Petros LM; Flanigan KM; Gesteland RF; Atkins JF
    Ann Neurol; 2000 Aug; 48(2):164-9. PubMed ID: 10939566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Read-through compound 13 restores dystrophin expression and improves muscle function in the mdx mouse model for Duchenne muscular dystrophy.
    Kayali R; Ku JM; Khitrov G; Jung ME; Prikhodko O; Bertoni C
    Hum Mol Genet; 2012 Sep; 21(18):4007-20. PubMed ID: 22692682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological Inhibition of PKCθ Counteracts Muscle Disease in a Mouse Model of Duchenne Muscular Dystrophy.
    Marrocco V; Fiore P; Benedetti A; Pisu S; Rizzuto E; Musarò A; Madaro L; Lozanoska-Ochser B; Bouché M
    EBioMedicine; 2017 Feb; 16():150-161. PubMed ID: 28089792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prednisolone attenuates improvement of cardiac and skeletal contractile function and histopathology by lisinopril and spironolactone in the mdx mouse model of Duchenne muscular dystrophy.
    Janssen PM; Murray JD; Schill KE; Rastogi N; Schultz EJ; Tran T; Raman SV; Rafael-Fortney JA
    PLoS One; 2014; 9(2):e88360. PubMed ID: 24551095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice.
    Ito K; Kimura S; Ozasa S; Matsukura M; Ikezawa M; Yoshioka K; Ueno H; Suzuki M; Araki K; Yamamura K; Miwa T; Dickson G; Thomas GD; Miike T
    Hum Mol Genet; 2006 Jul; 15(14):2266-75. PubMed ID: 16777842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of dystrophin in mice reduces NO-dependent vascular function and vascular density: total recovery after a treatment with the aminoglycoside gentamicin.
    Loufrani L; Dubroca C; You D; Li Z; Levy B; Paulin D; Henrion D
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):671-6. PubMed ID: 14751810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gentamicin administration in Duchenne patients with premature stop codon. Preliminary results.
    Politano L; Nigro G; Nigro V; Piluso G; Papparella S; Paciello O; Comi LI
    Acta Myol; 2003 May; 22(1):15-21. PubMed ID: 12966700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
    Siemionow M; Langa P; Brodowska S; Kozlowska K; Zalants K; Budzynska K; Heydemann A
    Stem Cell Rev Rep; 2022 Dec; 18(8):2872-2892. PubMed ID: 35590083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice.
    Ebihara S; Guibinga GH; Gilbert R; Nalbantoglu J; Massie B; Karpati G; Petrof BJ
    Physiol Genomics; 2000 Sep; 3(3):133-44. PubMed ID: 11015608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-Acetylcysteine ameliorates skeletal muscle pathophysiology in mdx mice.
    Whitehead NP; Pham C; Gervasio OL; Allen DG
    J Physiol; 2008 Apr; 586(7):2003-14. PubMed ID: 18258657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative effects of dystrophin loss on metabolic function of the mdx mouse.
    Strakova J; Kamdar F; Kulhanek D; Razzoli M; Garry DJ; Ervasti JM; Bartolomucci A; Townsend D
    Sci Rep; 2018 Sep; 8(1):13624. PubMed ID: 30206270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gentamicin treatment in exercised mdx mice: Identification of dystrophin-sensitive pathways and evaluation of efficacy in work-loaded dystrophic muscle.
    De Luca A; Nico B; Rolland JF; Cozzoli A; Burdi R; Mangieri D; Giannuzzi V; Liantonio A; Cippone V; De Bellis M; Nicchia GP; Camerino GM; Frigeri A; Svelto M; Camerino DC
    Neurobiol Dis; 2008 Nov; 32(2):243-53. PubMed ID: 18694830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutraceutical and pharmaceutical cocktails did not improve muscle function or reduce histological damage in D2-mdx mice.
    Spaulding HR; Quindry T; Hammer K; Quindry JC; Selsby JT
    J Appl Physiol (1985); 2019 Oct; 127(4):1058-1066. PubMed ID: 31295065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrin-like repeats from dystrophin and alpha-actinin-2 are not functionally interchangeable.
    Harper SQ; Crawford RW; DelloRusso C; Chamberlain JS
    Hum Mol Genet; 2002 Aug; 11(16):1807-15. PubMed ID: 12140183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.